Trial intelligence / Profile preview

Remimazolam vs midazolam for sedation in elderly mechanically ventilated ICU patients

ChiCTR2300078823Phase 4Recruiting

Sponsor
First Affiliated Hospital of Soochow University
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in respiratory failure and critical illness (2 arms), sponsored by First Affiliated Hospital of Soochow University. Primary endpoint: Sedation compliance rate. Started Jul 2022; status: recruiting.

02

Drugs

remimazolam
03

Conditions

respiratory failurecritical illness

Beyond the preview

Go deeper on ChiCTR2300078823.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300078823.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call